Qube Research & Technologies (QRT)
FULC icon

Qube Research & Technologies (QRT)’s Fulcrum Therapeutics FULC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.48M Buy
974,739
+582,250
+148% +$5.4M 0.01% 1459
2025
Q4 		$4.44M Buy
+392,489
New +$3.99M ﹤0.01% 1836
2024
Q3 		– Sell
-553,307
Closed -$3.43M – 3585
2024
Q2 		$3.43M Sell
553,307
-169,856
-23% -$1.29M 0.01% 1427
2024
Q1 		$6.83M Buy
723,163
+480,255
+198% +$4.29M 0.01% 1044
2023
Q4 		$1.64M Buy
242,908
+229,842
+1,759% +$1.02M ﹤0.01% 1643
2023
Q3 		$58K Buy
+13,066
New +$57.1K ﹤0.01% 2826
2022
Q3 		– Sell
-31,813
Closed -$156K – 2668
2022
Q2 		$156K Buy
+31,813
New +$311K ﹤0.01% 1795

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FULC Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Fulcrum Therapeutics (FULC) stake by 148% in Q1 2026, buying an estimated $5.4M and bringing the position to 974,739 shares worth $7.48M. The position accounts for 0.01% of the portfolio, ranked #1459.

Qube Research & Technologies (QRT) first reported a position in FULC in Q2 2022 and has held it in 7 quarters since. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • Qube Research & Technologies (QRT) held 974,739 shares of Fulcrum Therapeutics worth $7.48M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 582,250 Fulcrum Therapeutics shares in Q1 2026, an estimated $5.4M.
  • Fulcrum Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1459 holding.
  • Qube Research & Technologies (QRT) first reported a position in Fulcrum Therapeutics in Q2 2022 and has held it in 7 quarters since.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.